Skip to main content
Top
Published in: Cancer Causes & Control 11/2012

01-11-2012 | Original paper

Screening practices of Australian men and women categorized as “at or slightly above average risk” of colorectal cancer

Authors: Driss Ait Ouakrim, Trevor Lockett, Alex Boussioutas, Louise Keogh, Louisa B. Flander, Ingrid Winship, Graham G. Giles, John L. Hopper, Mark A. Jenkins

Published in: Cancer Causes & Control | Issue 11/2012

Login to get access

Abstract

Purpose

Australia has one of the highest incidences of colorectal cancer (CRC) in the world. In 2006, the federal government introduced a screening program consisting of a one-off fecal occult blood test offered to people turning 50, 55, or 65 years. We conducted a population-based study to estimate CRC screening practices existing outside the current program.

Methods

A total of 1887 unaffected subjects categorized “at or slightly above average risk” of CRC were selected from the Australasian Colorectal Cancer Family Registry. We calculated the proportions of participants that reported appropriate, under- and over-screening according to national guidelines. We performed a logistic regression analysis to evaluate associations between over-screening and a set of socio-demographic factors.

Results

Of 532 participants at average risk of CRC, eligible for screening, 4 (0.75 %) reported appropriate screening, 479 (90 %) reported never having been screened, 18 (3 %) reported some but less than appropriate screening, and 31 (6 %) reported over-screening. Of 412 participants aged 50 years or over, slightly above average risk of CRC, 1 participant (0.25 %) reported appropriate screening, 316 (77 %) reported no screening, and 11 (3 %) reported some but less than appropriate screening. Among participants under age 50 years, 2 % of those at average risk and 10 % of those slightly above average risk reported over-screening. Middle-aged people, those with a family history of CRC and those with a university degree, were more likely to be over-screened.

Conclusion

Overall, the level of CRC screening participation was low and the vast majority of screening tests undertaken were inappropriate in terms of timing, modality, or frequency.
Literature
2.
4.
go back to reference Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med 328(19):1365–1371. doi:10.1056/NEJM199305133281901 PubMedCrossRef Mandel JS, Bond JH, Church TR, Snover DC, Bradley GM, Schuman LM, Ederer F (1993) Reducing mortality from colorectal cancer by screening for fecal occult blood. Minnesota colon cancer control study. N Engl J Med 328(19):1365–1371. doi:10.​1056/​NEJM199305133281​901 PubMedCrossRef
6.
go back to reference Rozen P, Winawer SJ, Waye JD, Burnand B, Harris JK, Wietlisbach V, Froehlich F, Vader J-P, Gonvers J–J, the ESG, Joseph DA, DeGroff AS, Hayes NS, Wong FL, Plescia M, Shapero TF, Hoover J, Paszat LF, Burgis E, Hsieh E, Rothwell DM, Rabeneck L, Hilsden RJ, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Habbema JDF, Armelao F, Paternolli C, Franceschini G, Franch R, Orlandi PG, Miori G, Avancini I, Togni M, Rossi M, Meggio A, Tasini E, Manfrini R, Giacomin D, Fasoli R, Faitini K, Mastromauro M, Costa S, Ridolfi F, Rosi P, de Pretis G, Bressler B, Lo C, Amar J, Whittaker S, Chaun H, Halparin L, Enns R, Brenner H, Altenhofen L, Hoffmeister M, Thiis-Evensen E, Seip B, Vatn MH, Hoff GS (2002) Prospects for the worldwide control of colorectal cancer through screening. Gastrointest Endosc 55(6):755–759PubMedCrossRef Rozen P, Winawer SJ, Waye JD, Burnand B, Harris JK, Wietlisbach V, Froehlich F, Vader J-P, Gonvers J–J, the ESG, Joseph DA, DeGroff AS, Hayes NS, Wong FL, Plescia M, Shapero TF, Hoover J, Paszat LF, Burgis E, Hsieh E, Rothwell DM, Rabeneck L, Hilsden RJ, Lansdorp-Vogelaar I, van Ballegooijen M, Zauber AG, Boer R, Wilschut J, Habbema JDF, Armelao F, Paternolli C, Franceschini G, Franch R, Orlandi PG, Miori G, Avancini I, Togni M, Rossi M, Meggio A, Tasini E, Manfrini R, Giacomin D, Fasoli R, Faitini K, Mastromauro M, Costa S, Ridolfi F, Rosi P, de Pretis G, Bressler B, Lo C, Amar J, Whittaker S, Chaun H, Halparin L, Enns R, Brenner H, Altenhofen L, Hoffmeister M, Thiis-Evensen E, Seip B, Vatn MH, Hoff GS (2002) Prospects for the worldwide control of colorectal cancer through screening. Gastrointest Endosc 55(6):755–759PubMedCrossRef
7.
8.
go back to reference Australian Institute of Health and Welfare (AIHW) (2010) ACIM (Australian Cancer Incidence and Mortality) Books. AIHW, Canberra Australian Institute of Health and Welfare (AIHW) (2010) ACIM (Australian Cancer Incidence and Mortality) Books. AIHW, Canberra
9.
go back to reference Commonwealth Department of Health and Family Services (1997) Australian health techonology advisory committee. Colorectal cancer screening. Australian Government Publishing Service, Canberra Commonwealth Department of Health and Family Services (1997) Australian health techonology advisory committee. Colorectal cancer screening. Australian Government Publishing Service, Canberra
15.
go back to reference Javanparast S, Ward P, Young G, Wilson C, Carter S, Misan G, Cole S, Jiwa M, Tsourtos G, Martini A, Gill T, Baratiny G, Matt MA (2010) How equitable are colorectal cancer screening programs which include FOBTs? A review of qualitative and quantitative studies. Prev Med 50(4):165–172. doi:10.1016/j.ypmed.2010.02.003 PubMedCrossRef Javanparast S, Ward P, Young G, Wilson C, Carter S, Misan G, Cole S, Jiwa M, Tsourtos G, Martini A, Gill T, Baratiny G, Matt MA (2010) How equitable are colorectal cancer screening programs which include FOBTs? A review of qualitative and quantitative studies. Prev Med 50(4):165–172. doi:10.​1016/​j.​ypmed.​2010.​02.​003 PubMedCrossRef
17.
go back to reference Ritvo P, Myers R, Del Giudice ME, Pazsat L, Cotterchio M, Howlett R, Mai V, Brown P, Sullivan T, Rabeneck L (2009) Fecal occult blood testing: people in Ontario are unaware of it and not ready for it. Can Fam Physician 55(2):176–177 e174PubMed Ritvo P, Myers R, Del Giudice ME, Pazsat L, Cotterchio M, Howlett R, Mai V, Brown P, Sullivan T, Rabeneck L (2009) Fecal occult blood testing: people in Ontario are unaware of it and not ready for it. Can Fam Physician 55(2):176–177 e174PubMed
18.
go back to reference Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ (2004) Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 100(10):2093–2103. doi:10.1002/cncr.20276 PubMedCrossRef Seeff LC, Nadel MR, Klabunde CN, Thompson T, Shapiro JA, Vernon SW, Coates RJ (2004) Patterns and predictors of colorectal cancer test use in the adult U.S. population. Cancer 100(10):2093–2103. doi:10.​1002/​cncr.​20276 PubMedCrossRef
20.
go back to reference Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, Potter JD, Templeton AS, Thibodeau S, Seminara D (2007) Colon cancer family registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 16(11):2331–2343. doi:10.1158/1055-9965.EPI-07-0648 PubMedCrossRef Newcomb PA, Baron J, Cotterchio M, Gallinger S, Grove J, Haile R, Hall D, Hopper JL, Jass J, Le Marchand L, Limburg P, Lindor N, Potter JD, Templeton AS, Thibodeau S, Seminara D (2007) Colon cancer family registry: an international resource for studies of the genetic epidemiology of colon cancer. Cancer Epidemiol Biomarkers Prev 16(11):2331–2343. doi:10.​1158/​1055-9965.​EPI-07-0648 PubMedCrossRef
21.
go back to reference Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6):1453–1456PubMedCrossRef Vasen HF, Watson P, Mecklin JP, Lynch HT (1999) New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 116(6):1453–1456PubMedCrossRef
25.
go back to reference Cockburn J, Paul C, Tzelepis F, McElduff P, Byles J (2002) Screening for bowel cancer among NSW adults with varying levels of risk: a community survey. Aust N Z J Public Health 26(3):236–241PubMedCrossRef Cockburn J, Paul C, Tzelepis F, McElduff P, Byles J (2002) Screening for bowel cancer among NSW adults with varying levels of risk: a community survey. Aust N Z J Public Health 26(3):236–241PubMedCrossRef
27.
29.
go back to reference Thomas RJ, Clarke VA (1998) Colorectal cancer: a survey of community beliefs and behaviours in Victoria. Med J Aust 169(1):37–40PubMed Thomas RJ, Clarke VA (1998) Colorectal cancer: a survey of community beliefs and behaviours in Victoria. Med J Aust 169(1):37–40PubMed
30.
go back to reference Schattner A, Gilad A (2002) Primary care physicians’ awareness and implementation of screening guidelines for colorectal cancer. Prev Med 35(5):447–452PubMedCrossRef Schattner A, Gilad A (2002) Primary care physicians’ awareness and implementation of screening guidelines for colorectal cancer. Prev Med 35(5):447–452PubMedCrossRef
31.
go back to reference Giveon S, Kahan E (2000) Patient adherence to family practitioners’ recommendations for breast cancer screening: a historical cohort study. Fam Pract 17(1):42–45PubMedCrossRef Giveon S, Kahan E (2000) Patient adherence to family practitioners’ recommendations for breast cancer screening: a historical cohort study. Fam Pract 17(1):42–45PubMedCrossRef
33.
go back to reference Olynyk JK, Aquilia S, Platell CF, Fletcher DR, Henderson S, Dickinson JA (1998) Colorectal cancer screening by general practitioners: comparison with national guidelines. Med J Aust 168(7):331–334PubMed Olynyk JK, Aquilia S, Platell CF, Fletcher DR, Henderson S, Dickinson JA (1998) Colorectal cancer screening by general practitioners: comparison with national guidelines. Med J Aust 168(7):331–334PubMed
35.
go back to reference Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Carey ML, Attia JR, McEvoy MA (2012) Colorectal cancer screening in Australia: a community-level perspective. Med J Aust 196(8):516–520PubMedCrossRef Courtney RJ, Paul CL, Sanson-Fisher RW, Macrae FA, Carey ML, Attia JR, McEvoy MA (2012) Colorectal cancer screening in Australia: a community-level perspective. Med J Aust 196(8):516–520PubMedCrossRef
36.
go back to reference Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR (1999) Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 282(15):1458–1465PubMedCrossRef Cabana MD, Rand CS, Powe NR, Wu AW, Wilson MH, Abboud PA, Rubin HR (1999) Why don’t physicians follow clinical practice guidelines? A framework for improvement. JAMA 282(15):1458–1465PubMedCrossRef
37.
go back to reference Ee HC, Olynyk JK (2009) Making sense of differing bowel cancer screening guidelines. Med J Aust 190(7):348–349PubMed Ee HC, Olynyk JK (2009) Making sense of differing bowel cancer screening guidelines. Med J Aust 190(7):348–349PubMed
38.
go back to reference Australian Institute of Health and Welfare & Australian Government Department of Health and Ageing (2009). National Bowel cancer screening program: annual monitoring report 2009. Cancer series no. 49. Cat. no. CAN 45. Canberra: AIHW Australian Institute of Health and Welfare & Australian Government Department of Health and Ageing (2009). National Bowel cancer screening program: annual monitoring report 2009. Cancer series no. 49. Cat. no. CAN 45. Canberra: AIHW
40.
go back to reference Vernon SW (1997) Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89(19):1406–1422PubMedCrossRef Vernon SW (1997) Participation in colorectal cancer screening: a review. J Natl Cancer Inst 89(19):1406–1422PubMedCrossRef
46.
go back to reference Viiala CH, Zimmerman M, Cullen DJ, Hoffman NE (2003) Complication rates of colonoscopy in an Australian teaching hospital environment. Intern Med J 33(8):355–359PubMedCrossRef Viiala CH, Zimmerman M, Cullen DJ, Hoffman NE (2003) Complication rates of colonoscopy in an Australian teaching hospital environment. Intern Med J 33(8):355–359PubMedCrossRef
49.
go back to reference Barrett T (2011) Bowel cancer screening programme under threat in Australia. Lancet Oncol 12(2):123PubMedCrossRef Barrett T (2011) Bowel cancer screening programme under threat in Australia. Lancet Oncol 12(2):123PubMedCrossRef
50.
go back to reference Flitcroft KL, Salkeld GP, Gillespie JA, Trevena LJ, Irwig LM (2010) Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice? Med J Aust 193(1):37–42PubMed Flitcroft KL, Salkeld GP, Gillespie JA, Trevena LJ, Irwig LM (2010) Fifteen years of bowel cancer screening policy in Australia: putting evidence into practice? Med J Aust 193(1):37–42PubMed
Metadata
Title
Screening practices of Australian men and women categorized as “at or slightly above average risk” of colorectal cancer
Authors
Driss Ait Ouakrim
Trevor Lockett
Alex Boussioutas
Louise Keogh
Louisa B. Flander
Ingrid Winship
Graham G. Giles
John L. Hopper
Mark A. Jenkins
Publication date
01-11-2012
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 11/2012
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-012-0067-y

Other articles of this Issue 11/2012

Cancer Causes & Control 11/2012 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine